Advocacy intelligence hub — real-time data for patient organizations
University of California, San Diego — PHASE1, PHASE2
Massachusetts General Hospital — PHASE1, PHASE2
Genetix Biotherapeutics Inc. — NA
Minoryx Therapeutics, S.L. — PHASE3
Calico Life Sciences LLC — PHASE1, PHASE2
Children's Hospital of Philadelphia — NA
Joanne Kurtzberg, MD — PHASE1
University of Utah
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Paul Orchard, MD, MD
University of Minnesota Medical Center
📍 MINNEAPOLIS, MN
Florian Eichler, MD, MD
Massachusetts General Hospital
📍 BOSTON, MA
Maria L Escolar, MD
NFRD Office, Pittsburgh, Pennsylvania, US
📍 CHAPEL HILL, NC
William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
📍 Bethesda, Maryland
Thomas J. Langan, MD
Clinical Director, Clinical Research, Institute for Myelin and Glial Exploration
Mitchell S Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY